Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF‐β expression and connective tissue features
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Fibromuscular dysplasia (FMD) is a rare, nonatherosclerotic arterial disease for which the molecular basis is unknown. We comprehensively studied 47 subjects with FMD, including physical examination, spine magnetic resonance imaging, bone densitometry, and brain magnetic resonance angiography. Inflammatory biomarkers in plasma and transforming growth factor β (TGF‐β) cytokines in patient‐derived dermal fibroblasts were measured by ELISA. Arterial pathology other than medial fibrodysplasia with multifocal stenosis included cerebral aneurysm, found in 12.8% of subjects. Extra‐arterial pathology included low bone density ( P <0.001); early onset degenerative spine disease (95.7%); increased incidence of Chiari I malformation (6.4%) and dural ectasia (42.6%); and physical examination findings of a mild connective tissue dysplasia (95.7%). Screening for mutations causing known genetically mediated arteriopathies was unrevealing. We found elevated plasma TGF‐β1 ( P =0.009), TGF‐β2 (P = 0.004) and additional inflammatory markers, and increased TGF‐β1 ( P =0.0009) and TGF‐β2 ( P =0.0001) secretion in dermal fibroblast cell lines from subjects with FMD compared to age‐ and gender‐matched controls. Detailed phenotyping of patients with FMD allowed us to demonstrate that FMD is a systemic disease with alterations in common with the spectrum of genetic syndromes that involve altered TGF‐β signaling and offers TGF‐β as a marker of FMD.—Ganesh, S. K., Morissette, R., Xu, Z., Schoenhoff, F., Griswold, B. F., Yang, J., Tong, L., Yang, M.‐L., Hunker, K., Sloper, L., Kuo, S., Raza, R., Milewicz, D. M., Francomano, C. A., Dietz, H. C., Van Eyk, J., McDonnell, N. B. Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF‐β expression and connective tissue features. FASEB J. 28, 3313–3324 (2014). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 5×
“When comparing FMD samples to the MFS group, we found alterations in TGF- 1, TGF2, MCP-1, SAA, ICAM-1, VCAM-1, and IL-8 that were in similar direction and magnitude.”
BackgroundInfluentialCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135 · cited 1×
“IL-8 is known to play an important role in endothelial cell survival, proliferation, and angiogenesis (40, 41).”
BackgroundTransforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome
Morissette, R., Schoenhoff, F., Xu, Z., Shilane, D. A., Griswold, B. F., Chen, W., Yang, J., Zhu, J., Fert-Bober, J., Sloper, L., et al. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000280 · Cited by 51
Self-citation
Cited by
Mechanotransduction and extracellular matrix homeostasis
Humphrey, J. D., Dufresne, E. R., & Schwartz, M. A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3896 · Cited by 2,124
Hayes, S. N., Kim, E. S. H., Saw, J., Adlam, D., Arslanian-Engoren, C., Economy, K. E., Ganesh, S. K., Gulati, R., Lindsay, M. E., Mieres, J. H., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000564 · Cited by 1,301
Self-citationFirst International Consensus on the diagnosis and management of fibromuscular dysplasia
Gornik, H. L., Persu, A., Adlam, D., Aparicio, L. S., Azizi, M., Boulanger, M., Bruno, R. M., de Leeuw, P., Fendrikova-Mahlay, N., Froehlich, J., et al. (2019) · Vascular Medicine · doi:10.1177/1358863x18821816 · Cited by 432
Self-citationRegulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
“…levels of active TGF-b have been reported in a variety of genetic diseases of connective tissue, including multiple myopathic states (Cohn et al. 2007), fibromuscular dysplasia (Ganesh et al. 2014), and geleophysic and acromicric dysplasias (Le Goff et al. 2011; Le Goff and Cormier-Daire 2012).”
BackgroundFirst international consensus on the diagnosis and management of fibromuscular dysplasia
Gornik, H. L., Persu, A., Adlam, D., Aparicio, L. S., Azizi, M., Boulanger, M., Bruno, R. M., De Leeuw, P., Fendrikova-Mahlay, N., Froehlich, J., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002019 · Cited by 113
“In a small cohort of patients with multifocal FMD, secretion of transforming growth factor (TGF)-beta1 and TGF-beta2 by dermal fibroblast cell lines was increased compared with matched controls [27].”
BackgroundResultSelf-citation
Metadata
- Authors
- Ganesh, S. K., Morissette, R., Xu, Z., Schoenhoff, F., Griswold, B. F., Yang, J., Tong, L., Yang, M., Hunker, K., Sloper, L., Kuo, S., Raza, R., Milewicz, D. M., Francomano, C. A., Dietz, H. C., Van Eyk, J., & McDonnell, N. B.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2014-04-14
- Volume
- 28
- Issue
- 8
- Pages
- 3313-3324
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2029479807
- Cited by
- 86
- References
- 4
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.